- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
CT found effective for Dx lung collapse in women
Using high-resolution CT scans to screen for lymphangioleiomyomatosis is cost-effective in women between the ages of 25 and 54 who don’t smoke and come to the emergency room for the first time with a collapsed lung, according to University of Cincinnati researchers.
Using high-resolution CT scans to screen for lymphangioleiomyomatosis is cost-effective in women between the ages of 25 and 54 who don’t smoke and come to the emergency room for the first time with a collapsed lung, according to University of Cincinnati researchers.
About 5% of women who fit the “model patient” profile-a 30-year old, nonsmoking woman who comes into the emergency room with a spontaneous lung collapse-test positive for lymphangioleiomyomatosis (LAM).
Screening for LAM with high-resolution CT is the most cost-effective strategy, with approximately $32,000 per quality-adjusted life year gained, the authors said. With this data, physicians will be able to intervene with therapies more quickly and enroll patients in clinical trials that may be able to slow progression of the disease.
The study will change future guideline recommendations on how to treat patients presenting with pneumothorax, according to Dr. John Heffner, past president of the American Thoracic Society.
The findings have been published online in the American Journal of Respiratory and Critical Care Medicine.
New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging
November 18th 2024Agreement on follow-up imaging was 41 percent more likely with recommendations by thoracic radiologists and 36 percent less likely on recommendations for follow-up nuclear imaging, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
